APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epigenetics Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Epigenetics Services Market Analysis and Forecast 2026-2032

6 March 2026190 pages

Choose your research edition.

Industry ResearchEpigenetics Services Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Epigenetics Services Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Epigenetics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epigenetics Services Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Epigenetics Services Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Epigenetics Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Epigenetics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Epigenetics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Epigenetics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Epigenetics Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Epigenetics Services include Bio-Rad, lllumina, QIAGEN, Thermo Fisher, Active Motif, Diagenode, Agilent, Merck Millipore and Abcam, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Epigenetics Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Epigenetics Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Epigenetics Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Epigenetics Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Epigenetics Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Epigenetics Services revenue, projected growth trends, production technology, application and end-user industry.

Epigenetics Services Segment by Company

Bio-Rad

lllumina

QIAGEN

Thermo Fisher

Active Motif

Diagenode

Agilent

Merck Millipore

Abcam

New England Biolabs+

PerkinEImer

Zymo Research

Epigenetics Services Segment by Type

DNA Methylation

Histone Modification

Others

Epigenetics Services Segment by Application

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Contract Research Organization (CRO)

Epigenetics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenetics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epigenetics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenetics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Epigenetics Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Epigenetics Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenetics Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Epigenetics Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DNA Methylation Major Player Table 3. Histone Modification Major Player Table 4. Others Major Player Table 5. Global Epigenetics Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Academic and Research Institutes Major Player Table 7. Pharmaceutical and Biotechnology Companies Major Player Table 8. Contract Research Organization (CRO) Major Player Table 9. Epigenetics Services Industry Trends Table 10. Epigenetics Services Industry Drivers Table 11. Epigenetics Services Industry Opportunities and Challenges Table 12. Epigenetics Services Industry Restraints Table 13. Global Epigenetics Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Epigenetics Services Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Epigenetics Services Market Share by Region (2021-2026) Table 16. Global Epigenetics Services Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Epigenetics Services Market Share by Region (2027-2032) Table 18. Global Epigenetics Services Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Epigenetics Services Revenue Market Share by Players (2021-2026) Table 20. Global Epigenetics Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Epigenetics Services Key Players Headquarters & Area Served Table 22. Global Epigenetics Services Players, Product Type & Application Table 23. Global Epigenetics Services Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Epigenetics Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Epigenetics Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Epigenetics Services Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Epigenetics Services Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Epigenetics Services Revenue Market Share by Type (2021-2026) Table 30. Global Epigenetics Services Revenue Market Share by Type (2027-2032) Table 31. Global Epigenetics Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Epigenetics Services Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Epigenetics Services Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Epigenetics Services Revenue Market Share by Application (2021-2026) Table 35. Global Epigenetics Services Revenue Market Share by Application (2027-2032) Table 36. Bio-Rad Company Information Table 37. Bio-Rad Business Overview Table 38. Bio-Rad Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Bio-Rad Epigenetics Services Product Portfolio Table 40. Bio-Rad Recent Development Table 41. lllumina Company Information Table 42. lllumina Business Overview Table 43. lllumina Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. lllumina Epigenetics Services Product Portfolio Table 45. lllumina Recent Development Table 46. QIAGEN Company Information Table 47. QIAGEN Business Overview Table 48. QIAGEN Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. QIAGEN Epigenetics Services Product Portfolio Table 50. QIAGEN Recent Development Table 51. Thermo Fisher Company Information Table 52. Thermo Fisher Business Overview Table 53. Thermo Fisher Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Thermo Fisher Epigenetics Services Product Portfolio Table 55. Thermo Fisher Recent Development Table 56. Active Motif Company Information Table 57. Active Motif Business Overview Table 58. Active Motif Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Active Motif Epigenetics Services Product Portfolio Table 60. Active Motif Recent Development Table 61. Diagenode Company Information Table 62. Diagenode Business Overview Table 63. Diagenode Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Diagenode Epigenetics Services Product Portfolio Table 65. Diagenode Recent Development Table 66. Agilent Company Information Table 67. Agilent Business Overview Table 68. Agilent Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Agilent Epigenetics Services Product Portfolio Table 70. Agilent Recent Development Table 71. Merck Millipore Company Information Table 72. Merck Millipore Business Overview Table 73. Merck Millipore Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Merck Millipore Epigenetics Services Product Portfolio Table 75. Merck Millipore Recent Development Table 76. Abcam Company Information Table 77. Abcam Business Overview Table 78. Abcam Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Abcam Epigenetics Services Product Portfolio Table 80. Abcam Recent Development Table 81. New England Biolabs+ Company Information Table 82. New England Biolabs+ Business Overview Table 83. New England Biolabs+ Epigenetics Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. New England Biolabs+ Epigenetics Services Product Portfolio Table 85. New England Biolabs+ Recent Development Table 86. PerkinEImer Company Information Table 87. PerkinEImer Business Overview Table 88. PerkinEImer Epigenetics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. PerkinEImer Epigenetics Services Product Portfolio Table 90. PerkinEImer Recent Development Table 91. Zymo Research Company Information Table 92. Zymo Research Business Overview Table 93. Zymo Research Epigenetics Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Zymo Research Epigenetics Services Product Portfolio Table 95. Zymo Research Recent Development Table 96. North America Epigenetics Services Revenue by Type (2021-2026) & (US$ Million) Table 97. North America Epigenetics Services Revenue by Type (2027-2032) & (US$ Million) Table 98. North America Epigenetics Services Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Epigenetics Services Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. North America Epigenetics Services Revenue by Country (2021-2026) & (US$ Million) Table 102. North America Epigenetics Services Revenue by Country (US$ Million) & (2027-2032) Table 103. Europe Epigenetics Services Revenue by Type (2021-2026) & (US$ Million) Table 104. Europe Epigenetics Services Revenue by Type (2027-2032) & (US$ Million) Table 105. Europe Epigenetics Services Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Epigenetics Services Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Epigenetics Services Revenue by Country (2021-2026) & (US$ Million) Table 109. Europe Epigenetics Services Revenue by Country (US$ Million) & (2027-2032) Table 110. China Epigenetics Services Revenue by Type (2021-2026) & (US$ Million) Table 111. China Epigenetics Services Revenue by Type (2027-2032) & (US$ Million) Table 112. China Epigenetics Services Revenue by Application (2021-2026) & (US$ Million) Table 113. China Epigenetics Services Revenue by Application (2027-2032) & (US$ Million) Table 114. Asia Epigenetics Services Revenue by Type (2021-2026) & (US$ Million) Table 115. Asia Epigenetics Services Revenue by Type (2027-2032) & (US$ Million) Table 116. Asia Epigenetics Services Revenue by Application (2021-2026) & (US$ Million) Table 117. Asia Epigenetics Services Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Epigenetics Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Asia Epigenetics Services Revenue by Region (US$ Million) & (2021-2026) Table 120. Asia Epigenetics Services Revenue by Region (US$ Million) & (2027-2032) Table 121. SAMEA Epigenetics Services Revenue by Type (2021-2026) & (US$ Million) Table 122. SAMEA Epigenetics Services Revenue by Type (2027-2032) & (US$ Million) Table 123. SAMEA Epigenetics Services Revenue by Application (2021-2026) & (US$ Million) Table 124. SAMEA Epigenetics Services Revenue by Application (2027-2032) & (US$ Million) Table 125. SAMEA Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. SAMEA Epigenetics Services Revenue by Country (2021-2026) & (US$ Million) Table 127. SAMEA Epigenetics Services Revenue by Country (US$ Million) & (2027-2032) Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Epigenetics Services Image Figure 2. Global Epigenetics Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epigenetics Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. DNA Methylation Image Figure 5. Histone Modification Image Figure 6. Others Image Figure 7. Global Epigenetics Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Epigenetics Services Market Size Share 2021 VS 2025 VS 2032 Figure 9. Academic and Research Institutes Image Figure 10. Pharmaceutical and Biotechnology Companies Image Figure 11. Contract Research Organization (CRO) Image Figure 12. Global Epigenetics Services Market Size (US$ Million) & (2021-2032) Figure 13. Global Epigenetics Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Epigenetics Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Epigenetics Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Epigenetics Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Epigenetics Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Epigenetics Services Revenue Market Share by Type (2021-2032) Figure 20. Global Epigenetics Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Epigenetics Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Epigenetics Services Revenue Market Share by Application (2021-2032) Figure 23. North America Epigenetics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Epigenetics Services Revenue Share by Type (2021-2032) Figure 25. North America Epigenetics Services Revenue Share by Application (2021-2032) Figure 26. North America Epigenetics Services Revenue Share by Country (2021-2032) Figure 27. United States Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Epigenetics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Epigenetics Services Revenue Share by Type (2021-2032) Figure 32. Europe Epigenetics Services Revenue Share by Application (2021-2032) Figure 33. Europe Epigenetics Services Revenue Share by Country (2021-2032) Figure 34. Germany Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Epigenetics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Epigenetics Services Revenue Share by Type (2021-2032) Figure 44. China Epigenetics Services Revenue Share by Application (2021-2032) Figure 45. Asia Epigenetics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Epigenetics Services Revenue Share by Type (2021-2032) Figure 47. Asia Epigenetics Services Revenue Share by Application (2021-2032) Figure 48. Asia Epigenetics Services Revenue Share by Region (2021-2032) Figure 49. Japan Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Epigenetics Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Epigenetics Services Revenue Share by Type (2021-2032) Figure 57. SAMEA Epigenetics Services Revenue Share by Application (2021-2032) Figure 58. SAMEA Epigenetics Services Revenue Share by Country (2021-2032) Figure 59. Brazil Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Epigenetics Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation
  • Histone Modification
  • Others
Applications
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organization (CRO)
Companies covered
  • Bio-Rad
  • lllumina
  • QIAGEN
  • Thermo Fisher
  • Active Motif
  • Diagenode
  • Agilent
  • Merck Millipore
  • Abcam
  • New England Biolabs+
  • PerkinEImer
  • Zymo Research

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Epigenetics Services Market by Type
  3. 1.2.1 Global Epigenetics Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Methylation
  5. 1.2.3 Histone Modification
  6. 1.2.4 Others
  7. 1.3 Epigenetics Services Market by Application
  8. 1.3.1 Global Epigenetics Services Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Academic and Research Institutes
  10. 1.3.3 Pharmaceutical and Biotechnology Companies
  11. 1.3.4 Contract Research Organization (CRO)
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Epigenetics Services Market Dynamics
  1. 2.1 Epigenetics Services Industry Trends
  2. 2.2 Epigenetics Services Industry Drivers
  3. 2.3 Epigenetics Services Industry Opportunities and Challenges
  4. 2.4 Epigenetics Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Epigenetics Services Market Perspective (2021-2032)
  2. 3.2 Global Epigenetics Services Growth Trends by Region
  3. 3.2.1 Global Epigenetics Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Epigenetics Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Epigenetics Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Epigenetics Services Revenue by Players
  2. 4.1.1 Global Epigenetics Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Epigenetics Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Epigenetics Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Epigenetics Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Epigenetics Services Key Players Headquarters & Area Served
  7. 4.4 Global Epigenetics Services Players, Product Type & Application
  8. 4.5 Global Epigenetics Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Epigenetics Services Market CR5 and HHI
  11. 4.6.3 2025 Epigenetics Services Tier 1, Tier 2, and Tier 3
5 Epigenetics Services Market Size by Type
  1. 5.1 Global Epigenetics Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Epigenetics Services Revenue by Type (2021-2032)
  3. 5.3 Global Epigenetics Services Revenue Market Share by Type (2021-2032)
6 Epigenetics Services Market Size by Application
  1. 6.1 Global Epigenetics Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Epigenetics Services Revenue by Application (2021-2032)
  3. 6.3 Global Epigenetics Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bio-Rad
  2. 7.1.1 Bio-Rad Company Information
  3. 7.1.2 Bio-Rad Business Overview
  4. 7.1.3 Bio-Rad Epigenetics Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bio-Rad Epigenetics Services Product Portfolio
  6. 7.1.5 Bio-Rad Recent Developments
  7. 7.2 lllumina
  8. 7.2.1 lllumina Company Information
  9. 7.2.2 lllumina Business Overview
  10. 7.2.3 lllumina Epigenetics Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 lllumina Epigenetics Services Product Portfolio
  12. 7.2.5 lllumina Recent Developments
  13. 7.3 QIAGEN
  14. 7.3.1 QIAGEN Company Information
  15. 7.3.2 QIAGEN Business Overview
  16. 7.3.3 QIAGEN Epigenetics Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 QIAGEN Epigenetics Services Product Portfolio
  18. 7.3.5 QIAGEN Recent Developments
  19. 7.4 Thermo Fisher
  20. 7.4.1 Thermo Fisher Company Information
  21. 7.4.2 Thermo Fisher Business Overview
  22. 7.4.3 Thermo Fisher Epigenetics Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Thermo Fisher Epigenetics Services Product Portfolio
  24. 7.4.5 Thermo Fisher Recent Developments
  25. 7.5 Active Motif
  26. 7.5.1 Active Motif Company Information
  27. 7.5.2 Active Motif Business Overview
  28. 7.5.3 Active Motif Epigenetics Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Active Motif Epigenetics Services Product Portfolio
  30. 7.5.5 Active Motif Recent Developments
  31. 7.6 Diagenode
  32. 7.6.1 Diagenode Company Information
  33. 7.6.2 Diagenode Business Overview
  34. 7.6.3 Diagenode Epigenetics Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Diagenode Epigenetics Services Product Portfolio
  36. 7.6.5 Diagenode Recent Developments
  37. 7.7 Agilent
  38. 7.7.1 Agilent Company Information
  39. 7.7.2 Agilent Business Overview
  40. 7.7.3 Agilent Epigenetics Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Agilent Epigenetics Services Product Portfolio
  42. 7.7.5 Agilent Recent Developments
  43. 7.8 Merck Millipore
  44. 7.8.1 Merck Millipore Company Information
  45. 7.8.2 Merck Millipore Business Overview
  46. 7.8.3 Merck Millipore Epigenetics Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Merck Millipore Epigenetics Services Product Portfolio
  48. 7.8.5 Merck Millipore Recent Developments
  49. 7.9 Abcam
  50. 7.9.1 Abcam Company Information
  51. 7.9.2 Abcam Business Overview
  52. 7.9.3 Abcam Epigenetics Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Abcam Epigenetics Services Product Portfolio
  54. 7.9.5 Abcam Recent Developments
  55. 7.10 New England Biolabs+
  56. 7.10.1 New England Biolabs+ Company Information
  57. 7.10.2 New England Biolabs+ Business Overview
  58. 7.10.3 New England Biolabs+ Epigenetics Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 New England Biolabs+ Epigenetics Services Product Portfolio
  60. 7.10.5 New England Biolabs+ Recent Developments
  61. 7.11 PerkinEImer
  62. 7.11.1 PerkinEImer Company Information
  63. 7.11.2 PerkinEImer Business Overview
  64. 7.11.3 PerkinEImer Epigenetics Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 PerkinEImer Epigenetics Services Product Portfolio
  66. 7.11.5 PerkinEImer Recent Developments
  67. 7.12 Zymo Research
  68. 7.12.1 Zymo Research Company Information
  69. 7.12.2 Zymo Research Business Overview
  70. 7.12.3 Zymo Research Epigenetics Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Zymo Research Epigenetics Services Product Portfolio
  72. 7.12.5 Zymo Research Recent Developments
8 North America
  1. 8.1 North America Epigenetics Services Revenue (2021-2032)
  2. 8.2 North America Epigenetics Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Epigenetics Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Epigenetics Services Revenue by Type (2027-2032)
  5. 8.3 North America Epigenetics Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Epigenetics Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Epigenetics Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Epigenetics Services Revenue by Application (2027-2032)
  9. 8.5 North America Epigenetics Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Epigenetics Services Revenue by Country
  11. 8.6.1 North America Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Epigenetics Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Epigenetics Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Epigenetics Services Revenue (2021-2032)
  2. 9.2 Europe Epigenetics Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Epigenetics Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Epigenetics Services Revenue by Type (2027-2032)
  5. 9.3 Europe Epigenetics Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Epigenetics Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Epigenetics Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Epigenetics Services Revenue by Application (2027-2032)
  9. 9.5 Europe Epigenetics Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Epigenetics Services Revenue by Country
  11. 9.6.1 Europe Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Epigenetics Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Epigenetics Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Epigenetics Services Revenue (2021-2032)
  2. 10.2 China Epigenetics Services Revenue by Type (2021-2032)
  3. 10.2.1 China Epigenetics Services Revenue by Type (2021-2026)
  4. 10.2.2 China Epigenetics Services Revenue by Type (2027-2032)
  5. 10.3 China Epigenetics Services Revenue Share by Type (2021-2032)
  6. 10.4 China Epigenetics Services Revenue by Application (2021-2032)
  7. 10.4.1 China Epigenetics Services Revenue by Application (2021-2026)
  8. 10.4.2 China Epigenetics Services Revenue by Application (2027-2032)
  9. 10.5 China Epigenetics Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Epigenetics Services Revenue (2021-2032)
  2. 11.2 Asia Epigenetics Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Epigenetics Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Epigenetics Services Revenue by Type (2027-2032)
  5. 11.3 Asia Epigenetics Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Epigenetics Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Epigenetics Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Epigenetics Services Revenue by Application (2027-2032)
  9. 11.5 Asia Epigenetics Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Epigenetics Services Revenue by Country
  11. 11.6.1 Asia Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Epigenetics Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Epigenetics Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Epigenetics Services Revenue (2021-2032)
  2. 12.2 SAMEA Epigenetics Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Epigenetics Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Epigenetics Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Epigenetics Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Epigenetics Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Epigenetics Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Epigenetics Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Epigenetics Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Epigenetics Services Revenue by Country
  11. 12.6.1 SAMEA Epigenetics Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Epigenetics Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Epigenetics Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst